Lifeline Scientific, Inc. announced consolidated earnings results for the year ended December 31, 2012. For the year, the company announced total revenue of $30,151,843 compared to $25,391,104 for the same period a year ago. Income from operations was $127,447 compared to $1,890,745 for the same period a year ago. Income before income taxes was $45,899 compared to $2,406,576 for the same period a year ago. Net loss was $463,684 compared to net income of $3,278,040 for the same period a year ago. Net loss attributable to the company was $210,844 or $0.01 per basic and diluted share compared to net income attributable to the company of $3,475,113 or $0.07 per diluted share for the same period a year ago. Net cash used in operating activities was $1,471,828 compared to $316,573 for the same period a year ago. Capital expenditures were $1,685,848 compared to $812,420 for the same period a year ago.

Lifeline Scientific, Inc. provided earnings guidance for the year ended December 31, 2012. The company expects to report that revenues for the full year 2012 grew to approximately $30 million against $25.4 million a year ago. Profit before tax for 2012 is expected to be at a lower level than that reported in 2011. This is primarily due to significant investment to drive and support geographic expansion in Europe, South America and China, completion of the development phase of the LifePort Liver Transporter product line, and changes in product mix impacting gross margin. The company also incurred significant legal expenses related to a lawsuit brought in June 2011 against a former vendor and competitor to the company. The company provided revenue guidance for the year 2013. Trading in January 2013 has been in line with management expectations and the company expect to see continued revenue growth for 2013, driven in particular by another year of solid performance outside of North America.

Lifeline Scientific Inc. reported unaudited consolidated earnings results for the six months ended June 30, 2012. For the six months, the company reported total revenue of USD 14,289,624 compared to USD 11,829,288 a year ago. Loss from operations was USD 231,547 compared to income from operations of USD 1,094,812 a year ago. Loss before income taxes was USD 275,101 compared to income before income taxes of USD 1,644,836 a year ago. Net loss attributable to the company was USD 393,070 or USD 0.02 per basic and diluted share compared to net income attributable to the company of USD 1,503,732 or USD 0.07 per diluted share a year ago. Net cash from operating activities was USD 202,728 compared to net cash used in operating activities of USD 2,140,242 a year ago. Capital expenditures were USD 1,201,918 compared to USD 171,118 a year ago.